Genisphere and Lankenau Institute for Medical
Research will develop a biomarker for ulcerative colitis and Crohn’s disease. Hopefully
this will help doctors better pinpoint what patients might actually have and
classify to what degree people have inflammatory bowel disease. A paper said
that the biomarker could classify the severity and outcome of ulcerative
colitis and able to tell who had colitis compared to those people that were
healthy. Better tests are needed for inflammatory bowel disease as we know a
colonoscopy can be a pain in the butt (thank you I will be here all week). The
test could also be applied to cervical cancer and wound healing.
No comments:
Post a Comment